The global DNA vaccines market is experiencing rapid growth owing to the factors such adoption of DNA vaccines in healthcare, low costs of DNA vaccines, and increasing investments in DNA technology. The increase in the prevalence of chronic diseases such as cancer, hepatitis, HIV and others are augmenting the growth of the global DNA vaccine market. Moreover, relative ease of large-scale manufacturing compared to traditional approach and less storage requirement are some of the key market drivers. The other factors augmenting the growth of the market includes increasing clinical trials for DNA vaccines both animal based and human based. Several DNA vaccine clinical trials have been recently completed or are currently ongoing, such as ZYC101 (Eisai Pharmaceuticals) has completed phase I trial. HPV-16 and HPV-18 E6/E7 are being evaluated in a phase I clinical trial (Inovio Pharmaceuticals). DNA vaccines have already made significant progress to date. Nearly 100 clinical trials are on-going in humans for a wide range of diseases, and there is a deep pipeline of preclinical projects.
However, uncertainty in regulatory policies and less penetration of DNA vaccine technology in the emerging economies is hindering the growth of the market. However, the increasing benefits offered by the DNA based vaccines and increasing awareness will have a positive impact on the growth of the market in the future.
The DNA vaccine market is segmented on the basis type, technology and application. On the basis of type, the market is segmented into animal DNA vaccine and human DNA vaccine. On the basis of technology, the market is bifurcated into Plasmid DNA vaccine and plasmid DNA delivery technology. On the basis of application, the market is divided into oncology, infectious diseases and others. The market for oncology based DNA vaccines and Infectious diseases is one of the largest segment for the DNA based vaccines. Clinical trials for DNA vaccines to treat cancer including metastatic melanoma, prostate, and pancreatic cancer, and other solid tumors, are showing promising results. Inovio Pharmaceuticals has also been working on a DNA-based vaccine for Zika since December 2015.
The global DNA vaccine market is analysed on the basis of the geographical regions that are contributing significantly towards the growth of the market. North America dominates the global DNA vaccine market due to the presence of all the major key pharmaceutical companies and increasing clinical trials. Europe is the second largest market followed by Asia pacific region. Asia pacific is the fastest growing segment due to increasing awareness about the benefits and flexibility offered by DNA vaccines.
The companies contributing to the growth of global DNA vaccine market are Astellas Pharma, Bharat Biotech, Dendreon Corporation, Indian Immunologicals Limited, GE Healthcare Life Sciences, GlaxoSmithKline Inc., Green Cross Corporation, Innovio Biomedical Corporation, Pfizer Pharmaceuticals, Sanofi, The Serum Institute of India Pvt. Limited, Zoetis Inc. and so on. US – AgriLabs in November 2017, announced the United States Department of Agriculture (USDA) approval of the first DNA vaccine licensed for chickens. The approval also represents the first for AgriLabs ExactVacTM DNA technology with ENABL adjuvant, the first DNA vaccine approved for influenza for veterinary use, and among the first DNA vaccines approved in the US for food animals.
- Global DNA vaccines market by type
- Global DNA vaccines market by technology
- Global DNA vaccines market by application
The market study of DNA vaccine market is incorporated by extensive primary and secondary research conducted by research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report country level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings the authenticity in our reports.
Secondary sources include:
- Financial reports of companies involved in the market
- Authentic Public Databases
- Whitepapers, research-papers and news blogs
- Company websites and their product catalogue.
- Supplier Websites such as Alibaba, amazon for pricing analysis.
The Report covers:
- Comprehensive Research Methodology of Global DNA Vaccine Market.
- This report also includes detailed and extensive market overview with Analyst insights & key market trends.
- Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the Global DNA Vaccine Market.
- Insights about market determinants which are stimulating the Global DNA Vaccine Market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders
2. Market Overview and Insights
2.2. Analyst Insights & Current Market Trends
2.2.1. Key Findings
2.3.1. United States
2.3.2. European Union
2.3.5. Rest of the World
2.4. Pipeline Analysis
3. Market Determinant
3.1.1. Increasing Prevalence of Chronic Disorders
3.1.2. Technological Advancements
3.1.3. Pipeline Products From Key Players to Boost the Dna Vaccine Market
3.1.4. Increasing Adoption of Dna Vaccines in Animal Healthcare
3.1.5. Low Cost of Dna Vaccines to Drive the Market
3.1.6. Increasing Investments in Dna Technology For Vaccine Production
3.2.1. Uncertainity in Regulatory Systems
3.2.2. Less Penetration of Dna Vaccines in the Developing Economies
3.3.1. Rising Awareness of the Dna Based Vaccines
4. Market Segmentation
4.1. Global Dna Vaccine Market By Type
4.1.1. Animal Dna Vaccine
4.1.2. Human Dna Vaccine
4.2. Global Dna Vaccine Market By Technology
4.2.1. Plasmid Dna Vaccines Technology
4.2.2. Plasmid Dna Delivery Technology
4.3. Global Dna Vaccine Market By Application
4.3.2. Infectious Diseases
5. Competitive Landscape
5.1.1. Key Company Analysis
5.1.2. Key Strategy Analysis
6. Regional Analysis
6.1. North America
6.1.1. United States
6.2.1. United Kingdom
6.2.6. Rest of Europe
6.3. Asia Pacific
6.4. Rest of the World
7. Company Profiles
7.1. Astellas Pharma
7.2. Bharat Biotech
7.3. Dendreon Corporation
7.4. Indian Immunologicals Limited
7.5. Ge Healthcare Life Sciences
7.6. Glaxosmithkline Inc.
7.7. Green Cross Corporation
7.8. Innovio Biomedical Corporation
7.9. Immunomic Therapeutics
7.10. Merck & Co.
7.11. Pfizer Pharmaceuticals
7.12. Protein Sciences Corporation
7.13. Qed Biosciences Inc.
7.16. Tekmira Pharmaceuticals
7.17. Tolerion Inc.
7.18. the Serum Institute of India Pvt. Limited
7.20. Xenetic Biosciences Inc.
7.21. Zoetis Inc.
List of Tables:
Table 1 Global Dna Vaccine Market Research and Analysis, By Type , 2017-2023 ($ Millions)
Table 2 Global Animal Dna Vaccine Market Research and Analysis 2017-2023 ($ Millions)
Table 3 Global Human Dna Vaccine Market Research and Analysis, 2017-2023, ($ Millions)
Table 4 Global Dna Vaccine Market Research and Analysis, By Technology 2017-2023, ($ Millions)
Table 5 Global Plasmid Dna Vaccine Market Research and Analysis, 2017-2023, ($ Millions)
Table 6 Global Plasmid Dna Delivery Market Research and Analysis, 2017-2023, ($ Millions
Table 7 Global Dna Vaccine Market Research and Analysis, By Application 2017-2023, ($ Millions)
Table 8 Global Oncology Dna Vaccine Market Research and Analysis, 2017-2023, ($ Millions)
Table 9 Global Infectious Diseases Dna Vaccine Market Research and Analysis, 2017-2023, ($ Millions)
Table 10 Global Others Dna Vaccine Market Research and Analysis, 2017-2023, ($ Millions)
List of Figures:
Figure 1 Global Dna Vaccine Market, By Type, 2017 and 2023 (%)
Figure 2 Global Dna Vaccine Market, By Technology, 2017 and 2023 (%)
Figure 3 Global Dna Vaccine Market, By Application, 2017 and 2023 (%)
Figure 4 Global Dna Vaccine Market, By Geography, 2017 and 2023 (%)
Figure 5 North America Market Research and Analysis, 2017-2023 ($ Millions)
Figure 6 Us Market Research and Analysis, 2017-2023 ($ Millions)
Figure 7 Canada Market Research and Analysis, 2017-2023 ($ Millions)
Figure 8 European Market Research and Analysis, 2017-2023 ($ Millions)
Figure 9 UK Market Research and Analysis, 2017-2023 ($ Millions)
Figure 10 France Market Research and Analysis, 2017-2023 ($ Millions)
Figure 11 Germany Market Research and Analysis, 2017-2023 ($ Millions)
Figure 12 Italy Market Research and Analysis, 2017-2023 ($ Millions)
Figure 13 Spain Market Research and Analysis, 2017-2023 ($ Millions)
Figure 14 ROE Market Research and Analysis, 2017-2023 ($ Millions)
Figure 15 Asia Pacific Market Research and Analysis, 2017-2023 ($ Millions)
Figure 16 India Market Research and Analysis, 2017-2023 ($ Millions)
Figure 17 China Market Research and Analysis, 2017-2023 ($ Millions)
Figure 18 Japan Market Research and Analysis, 2017-2023 ($ Millions)
Figure 19 ROAPAC Market Research and Analysis, 2017-2023 ($ Millions)
Figure 20 Rest of the World Market Research and Analysis, 2017-2023 ($ Millions)
- Astellas Pharma
- Bharat Biotech
- Dendreon Corporation
- Indian Immunologicals Limited
- Ge Healthcare Life Sciences
- Glaxosmithkline Inc.
- Green Cross Corporation
- Innovio Biomedical Corporation
- Immunomic Therapeutics
- Merck & Co.
- Pfizer Pharmaceuticals
- Protein Sciences Corporation
- Qed Biosciences Inc.
- Tekmira Pharmaceuticals
- Tolerion Inc.
- The Serum Institute Of India Pvt. Limited
- Xenetic Biosciences Inc.
- Zoetis Inc.